Analyst Ratings for Haemonetics Corp. (HAE)Updated: 2017-07-27
An average rating of Hold has been given to Haemonetics Corp. (NYSE:HAE) by analysts covering the stock. About 30 days ago, HAE was issued an average rating of Hold.
9 analysts issued ratings on the stock, where 2 gave HAE a buy rating, 0 issued an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
A number of analysts gave price targets for HAE. The most optimistic analyst gave a price target of 50, which equates to a potential upside of 26.52 percent. The most pessimistic analyst gave a price target of 38, implying a possible loss of -3.85 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.
Analysts have revised their earnings estimates downwards for this quarter, by about -1.56 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is 0 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0.32 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.88 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts made negative revisions. Also over the last month, 2 analysts increased their estimates for the FY earnings, while 1 analysts made negative revisions to their fiscal year's estimates.
HAE has a 52-week high of 43.62 and a 52-week low of 29.75. Currently the stock is 32.84 percent higher than its low, and 9.4 percent below the high. HAE has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HAE value stock report compares HAE to some of its peers using value stock charts. The market cap of HAE is $2.08 billion. HAE's next earnings release will be on 0000-00-00, which is days away.